
Sphere Fluidics Trademarks Cyto-Mine
Sphere Fluidics has filed a Trademark for Cyto-Mine, its new single cell analysis instrument, in Europe. “We are also trademarking this novel, brand name in the US and will consider other regions shortly.” said Dr Frank F. Craig (CEO). “Sphere Fluidics believes that this technology will be breakthrough for biopharmaceutical discovery and development. To date, we have taken great care in developing our IP portfolio and will continue to do so to ensure protection of our valuable assets”.